ELIEM THERAPEUTICS (UK) LTDActive

Company number 11893311Private limited companyIncorporated 2019

Key figures

£80,168-99.3%
Net assets 2024
-73.0%
Average annual change 2020–2024
010 m20 m30 m20202021202220232024

ELIEM THERAPEUTICS (UK) LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 m20 m30 m20202021202220232024
Filed accounts2020–2024
20202021202220232024
Profit for the year-7,154,377-20,140,870-47,413,354-17,171,077-13,057,962
Cash at bank and in hand1,092,8043,908,40412,303,3853,508,58349,544
Total assets16,413,26511,132,91221,717,2765,704,476161,310
Total liabilities1,361,0893,347,1843,778,8731,920,82781,142
Net assets / total equity15,052,17618,859,82525,779,87011,156,96880,168
Average number of employees41424216

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2024

The principal activity of the company continued to be that of research and development.

As described in the company's latest filed accounts.

Summary: ELIEM THERAPEUTICS (UK) LTD

Company

ELIEM THERAPEUTICS (UK) LTD is a private limited company registered with Companies House under company number 11893311. It was incorporated on 20 Mar 2019. Its status is active. The registered office is in Altrincham (WA14). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts. Loss for the year was £13,057,962. Net assets were £80,168, down 99.3% on the previous year. Cash at bank and in hand was £49,544. Total assets were £161,310 and total liabilities £81,142. The company had an average of 6 employees. Figures are available for 5 financial years (2020–2024).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 2 Apr 2027.